1 / 1
Avelumab(Bavencio)
Acetylcysteine Injection, FLUIMUCIL, Acetylcysteine InjectionAcetylcysteine Injection, FLUIMUCIL, Acetylcysteine InjectionAcetylcysteine Injection, FLUIMUCIL, Acetylcysteine Injection
Reference price:
Manufacturer:
Pfizer Inc.
Formulation:
INJECTION
Validity period:
24 months
Reminder: The outer packaging is for reference only, please purchase and use under the guidance of
a
pharmacist. For read by medical and pharmaceutical professionals only.
Bavencio(Avelumab) Instructions:Uses,Dosage, Side Effects
BAVENCIO (avelumab) is a human monoclonal antibody that functions as a programmed death ligand-1 (PD-L1) blocking antibody. It is produced in Chinese hamster ovary cells and has an approximate molecular weight of 147 kDa. By binding to PD-L1, BAVENCIO blocks its interactions with the PD-1 and B7.1 receptors, thereby releasing inhibitory brakes on the immune response and potentially restoring anti-tumor immunity. It is formulated as a sterile, preservative-free solution for intravenous infusion and is supplied in single-dose vials.
